COO Moves this week include:
|OpenWorks||SEACOR Marine Holdings Inc.||Intuitive|
|ADARA||Athira Pharma, Inc.||OncoCell MDx™|
|AEX Gold Inc.||LightPath Technologies, Inc.||Sanmina Corporation|
Would you like to receive our weekly COO Moves directly in your email? Click the SIGN ME UP! button on the right of the blog page.
Should you have any COO Moves to report, please email us.
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
OpenWorks [PHOENIX, AZ] has appointed Liz Caracciolo as its Chief Operating Officer. Prior to joining OpenWorks, Caracciolo was General Manager of Government Solutions and Vice President of Corporate Development at technology and software companies including Verra Mobility and Billing Tree. Caracciolo also served as Director of New Product and Service Development for Bank of America Merrill Lynch.
SEACOR Marine Holdings Inc. [HOUSTON, TX] (NYSE: SMHI) announced that Robert Clemons has stepped down as Executive Vice President and Chief Operating Officer. Clemons joined SEACOR Marine as Executive Vice President and Chief Operating Officer in June of 2017 and was previously the Vice President and Chief Operating Officer of SEACOR Holdings Inc.’s Americas offshore division.
Intuitive [SUNNYVALE, CA] (NASDAQ: ISRG) announced Sal Brogna’s intent to transition from his role as Executive Vice President and Chief Operating Officer. Brogna will remain with Intuitive through the end of 2019 and plans to serve as a consultant and advisor to the company starting in 2020.
ADARA [PALO ALTO, CA] announced that Frank Teruel as Chief Operating Officer. Most recently, Teruel led ThreatMetrix through rapid global growth and expansion to new industries culminating in an $830 million sale to LexisNexis Risk Solutions. Previously, Teruel held executive management positions at Vormetric and other software companies.
Athira Pharma, Inc. [SEATTLE, WA] announced the appointment of Mark Litton as Chief Operating Officer. Litton is co-founder of Alder BioPharmaceuticals, where he served as Chief Business Officer and Treasurer from 2004 to 2018. Prior to co-founding Alder BioPharmaceuticals, highlights from Litton’s experience spans executive leadership positions including Vice President of Business Development at Celltech Group, Vice President of Business Development at Chiroscience Group plc, and Manager of Business Development for Ribozyme.
OncoCell MDx™ [ROYAL OAK, MI] announced the appointment of Christopher Thibodeau as its Chief Operating Officer. Thibodeau most recently served as Chief Operating Officer for MDxHealth. Previously, Christopher held various leadership positions at Agendia, Numira Biosciences, US LABS and Ventana Medical Systems.
LightPath Technologies, Inc. [ORLANDO, FL] (NASDAQ: LPTH) announced the appointment of Al Symmons as Chief Operating Officer. Since joining LightPath in 2006, Al Symmons has successfully served in progressively responsible positions leading up to his appointment as COO in July 2019. Most recently, Symmons served as EVP of Operations, and he previously held the titles of Vice President of Corporate Engineering and Director of Engineering. Prior to joining LightPath, he was Engineering Manager at Aurora Optical, and held various management engineering positions in injection molded plastic optics at both Applied Image Group – Optics, and Donnelly Optics.
Sanmina Corporation [SAN JOSE, CA] (NASDAQ: SANM) announced Hartmut Liebel has joined the Company as President and Chief Operating Officer. Liebel most recently served as President and Chief Executive Officer of privately owned iQor. Liebel previously spent over ten years at Jabil Inc. in various leadership roles including Chief Executive Officer of Aftermarket Services. Liebel’s portfolio of technology and financial industry experience also includes Director, Business Development at Artesyn Technologies; Assistant Treasurer at WR Grace; and Vice President, Currency and Derivatives at Continental Bank.